The method relies on differential cell density during centrifugation. When a blood or biological sample is layered over a separation medium, cellular components move to different positions rather than remaining uniformly mixed. Mononuclear cells accumulate at a recognizable interface, whereas erythrocytes and granulocytes sediment separately. This physical partitioning creates an enriched fraction for subsequent cancer research analyses.
The interface marks the location where the desired enriched fraction can be recovered after centrifugation. Its position reflects the separation of mononuclear cells from erythrocytes and granulocytes. Collecting this region rather than the entire sample reduces the contribution of those other blood-cell populations, making immune profiling and functional measurements more focused.
Enrichment of the mononuclear fraction directs experiments toward lymphocytes and monocytes rather than the mixed cellular composition of the starting material. This is useful when investigators need to characterize immune responses, examine tumor microenvironment samples, or perform functional assays in which the contribution of these populations must be evaluated.
A basic workflow starts by layering the biological sample over a separation medium, followed by centrifugation. The resulting positions of the cell populations are then used to identify and recover the mononuclear interface. This sequence converts a mixed sample into an enriched population suitable for downstream analysis, including immune profiling, biomarker analysis, or functional assays.
Cancer researchers use the enriched cell population to study immune responses associated with tumors and to investigate the tumor microenvironment. The approach can support analysis of immune cells circulating in biological samples or infiltrating tumor-associated sites. It is therefore relevant to experiments examining relationships between immune cells and cancer cells.
These fractions can provide material for biomarker analysis, functional assays, and characterization of treatment-related effects. By focusing on lymphocytes and monocytes, investigators can assess changes in immune responses and examine how immune-cell populations interact with cancer cells. The resulting data help connect cellular composition with tumor biology and experimental treatment outcomes.